Childhood and early-onset anxiety: Treatment and biomarker studies

James T. McCracken*, John T. Walkup, Harold S. Koplewicz

*Corresponding author for this work

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Increasing research attention is being applied to studies of early-onset anxiety, with a focus on its phenomenology, etiology, and strategies for treatment. The impetus for these studies includes well-confirmed findings from epidemiologic surveys clearly demonstrating that, as a group, the anxiety disorders represent the most highly prevalent form of psychopathology in children and adolescents. Overall rates of childhood anxiety disorders are estimated to be from 6% to 10%, depending upon categories included and strategies for ascertainment. New work is currently being conducted in the form of large-scale rigorous treatment studies, and new investigations explore etiopathophysiologic aspects of anxiety in children and adolescents. Significant progress is being made in this important clinical area that should translate to improved outcomes through refined diagnosis and empirically tested treatments.

Original languageEnglish (US)
Pages (from-to)8-11
Number of pages4
JournalJournal of Clinical Psychiatry
Volume63
Issue numberSUPPL. 6
StatePublished - May 6 2002

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Childhood and early-onset anxiety: Treatment and biomarker studies'. Together they form a unique fingerprint.

  • Cite this